Hyderabad, 04 December 2023: Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals,
Continue ReadingGranules India Limited Received ANDA Approval for Sildenafil for Oral Suspension